Diagnostics Biochem Canada

Diagnostics Biochem Canada (DBC) is a specialized biotechnology company that develops and manufactures high-quality immunoassay test kits for the global in vitro diagnostics market. Established in 1973 and based in London, Ontario, the company offers an extensive portfolio of ELISA, CLIA, and RIA kits focusing on endocrinology, oncology, and fertility. Their products are utilized by clinical laboratories and research centers worldwide to measure steroid hormones, thyroid markers, and tumor-associated antigens. In 2024, DBC was acquired by Snibe (Shenzhen New Industries Biomedical Engineering), a move aimed at expanding their global reach and integrating DBC's specialized assay expertise with Snibe's automated platforms. The company maintains rigorous quality standards, including ISO 13485 certification and MDSAP compliance.